Showing results (221-230 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|August 18, 2000
Cost effectiveness of combination HIV therapy: 3 years laterR D MoorePharmacoeconomics|August 18, 2000
Cost analysis of the treatment of schizophrenia in the UK. A simulation model comparing olanzapine, risperidone and haloperidolS Almond, O O'DonnellPharmacoeconomics|September 30, 2000
Introduction to the pharmacoeconomics of herbal medicinesP A De Smet, G Bonsel, A Van der Kuy, et al.Pharmacoeconomics|September 30, 2000
Long-term treatment of multiple sclerosis with interferon-beta may be cost effectiveM Kendrick, K I JohnsonPharmacoeconomics|September 30, 2000
Using economic evaluations to make formulary coverage decisions. So much for guidelinesA H Anis, Y GagnonPharmacoeconomics|September 30, 2000
The impact of pituitary adenoma on morbidity. Increased sick leave and disability retirement in a cross-sectional analysis of Swedish national dataB Jonsson, B NilssonPharmacoeconomics|August 18, 2000
Bridging decision analytic modelling with a cross-sectional study. Application to Parkinson's diseaseM J NuijtenPharmacoeconomics|June 6, 1998
The role of pharmacoeconomic evaluations in disease managementK Chang, D NashPharmacoeconomics|June 6, 1998
Risperidone. A pharmacoeconomic review of its use in schizophreniaR H Foster, K L GoaPageof 335